Search results
Tango drops USP1 inhibitor over liver toxicity in patients during phase 1 trial
FierceBiotech· 3 days agoThe plan had been to add AstraZeneca’s and Merck & Co.’s PARP inhibitor Lynparza into the mix as a...
HPV vaccine can have big health benefits for men, research shows
Morningstar· 1 day agoA vaccine that's widely known to help protect women from cervical cancer can also offer significant health benefits for men, new research shows. Human papillomavirus vaccination is linked with ...
Eli Lilly pays Aktis $60M upfront to further dial into radiopharma signal
FierceBiotech· 5 days agoEli Lilly is continuing to ride the radiopharma wave, paying Aktis Oncology $60 million upfront to...
Boston radiopharmaceuticals startup inks deal worth up to $1.16B with Lilly - Boston Business...
The Business Journals· 5 days agoA Boston radiopharmaceuticals startup that is already backed by three Big Pharma companies now has a...
Medicenna to Present Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming Sachs 10th Annual...
Digital Journal· 4 days agoMedicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines, announced today that it ...
The Supreme Court Affirms the Availability of Damages Beyond Three Years for Copyright Infringement...
JD Supra· 7 days agoOn May 9, 2024, the Supreme Court issued its decision in Warner Chappell Music Inc. et al. v. Nealy et al., holding that a plaintiff can seek damages for past infringement that had occurred ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 5 days agoGlobal Antibiotics Market Projected to Reach $49.6 Billion by 2027 PR Newswire BOSTON, May 22, 2024 Global Antibiotics Market, as forecasted by BCC Research, to Grow at a Compound Annual Growth Rate (CAGR) of 4.2% Through 2027 BOSTON, May 22, 2024
Invivyd appoints two new directors to its board By Investing.com
Investing.com· 4 days agoInvivyd Inc. (NASDAQ:IVVD), a biopharmaceutical company, announced the election of two new...
Victory for drugmakers GSK and Boehringer in $640 million Zantac cancer lawsuit
Fortune· 3 days agoJurors on Thursday found that GSK and Boehringer weren’t liable for Angela Valadez’s injuries and that the companies had properly marketed the drug without a warning about its alleged cancer ...
Why Merck (MRK) is a Top Momentum Stock for the Long-Term
Zacks· 5 days agoFor new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...